Population Pharmacokinetic Analysis and Dosing Optimization of Colistin Sulfate in Lung Transplant Recipients with Pneumonia: A Prospective Study

Currently, there is a lack of information on the clinical pharmacokinetics (PK), effectiveness, and safety of colistin sulfate in lung transplant recipients. This study aims to improve colistin sulfate dosing regimens and evaluate its population pharmacokinetics (PopPK) in lung transplant recipients.